Looking Into Precision BioSciences’s Return On Capital Employed
Precision BioSciences (NASDAQ:DTIL) brought in sales totaling $6.34 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 97.62%, resulting in a loss of $22.29 million.
Goldman Sachs Maintains Neutral on Precision BioSciences, Lowers Price Target to $5
Goldman Sachs maintains Precision BioSciences (NASDAQ:DTIL) with a Neutral and lowers the price target from $12 to $5.
68 Biggest Movers From Yesterday
Gainers
Sonim Technologies, Inc. (NASDAQ: SONM) shares jumped 103.3% to settle at $1.22 on Tuesday after the company announced its XP8 smartphone has integrated with the Walkie Talkie in Microsoft Teams.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 454 stocks hit new 52-week lows.
Recap: Precision BioSciences Q4 Earnings
Precision BioSciences (NASDAQ:DTIL) reported its Q4 earnings results on Tuesday, March 15, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Preview: Precision BioSciences’s Earnings
Precision BioSciences (NASDAQ:DTIL) is set to give its latest quarterly earnings report on Tuesday, 2022-03-15. Here's what investors need to know before the announcement.
Analysts estimate that Precision BioSciences will report an earnings per share (EPS) of $-0.47.
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb’s Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments served as catalysts during the week.
